Skip to main content
logo
Yarrow Bioscience, Inc. (YARW)
NASDAQ: YARW · Real-Time Price · USD
30.21
+1.36 (4.71%)
At close: Sep 4, 2026, 4:00 PM EDT
28.80
-1.41 (-4.67%)
After-hours: Sep 4, 2026, 7:30 PM EDT

Yarrow Bioscience Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
FY 2025
Period Ending
Dec '25
Cash & Equivalents
99.99
Cash & Short-Term Investments
99.99
Cash Growth
-
Prepaid Expenses
0.01
Total Current Assets
100
Long-Term Deferred Charges
0.41
Total Assets
100.41

Liabilities

Fiscal Year
FY 2025
Period Ending
Dec '25
Accounts Payable
1.53
Accrued Expenses
70.01
Total Current Liabilities
71.55
Total Liabilities
71.55

Shareholders' Equity

Fiscal Year
FY 2025
Period Ending
Dec '25
Additional Paid-In Capital
0
Retained Earnings
-70.99
Total Common Equity
-70.99
Shareholders' Equity
28.86
Total Liabilities & Equity
100.41

Additional Metrics

Fiscal Year
FY 2025
Period Ending
Dec '25
Net Cash (Debt)
99.99
Net Cash Growth
-
Net Cash Per Share
23.53
Filing Date Shares Outstanding
4.25
Total Common Shares Outstanding
4.25
Working Capital
28.45
Book Value Per Share
-16.70
Tangible Book Value
-70.99
Tangible Book Value Per Share
-16.70
SEC Filings: 10-K · 10-Q